Allergy Therapeutics
AGY.L
#6938
Rank
โ‚ฌ0.38 B
Marketcap
8,17ย โ‚ฌ
Share price
6.92%
Change (1 day)
21,767.93%
Change (1 year)

Revenue for Allergy Therapeutics (AGY.L)

Revenue in 2024: โ‚ฌ61.42 Million

According to Allergy Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ61.42 Million. In 2024 the company made a revenue of โ‚ฌ61.42 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ66.1 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Allergy Therapeutics from 2002 to 2024

Annual revenue

Year Revenue Change
2024โ‚ฌ61.42 M-7.09%
2023โ‚ฌ66.1 M-14.85%
2022โ‚ฌ77.64 M-24.38%
2021โ‚ฌ0.10 B21.26%
2020โ‚ฌ84.67 M2.87%
2019โ‚ฌ82.3 M3.66%
2018โ‚ฌ79.39 M8.18%
2017โ‚ฌ73.39 M27.75%
2016โ‚ฌ57.45 M-3.95%
2015โ‚ฌ59.81 M-4.84%
2014โ‚ฌ62.85 M19.6%
2013โ‚ฌ52.55 M-7.74%
2012โ‚ฌ56.95 M-3.05%
2011โ‚ฌ58.74 M9.69%
2010โ‚ฌ53.55 M-2.05%
2009โ‚ฌ54.68 M0.56%
2008โ‚ฌ54.37 M19.97%
2007โ‚ฌ45.32 M18.31%
2006โ‚ฌ38.31 M18.08%
2005โ‚ฌ32.44 M12.59%
2004โ‚ฌ28.81 M14.69%
2003โ‚ฌ25.12 M23.14%
2002โ‚ฌ20.4 M